Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 1,031.20
-2.95 (-0.29%)
At close: Jul 18, 2025
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 16,571 employees as of March 31, 2025. The number of employees increased by 1,713 or 11.53% compared to the previous year.
Employees
16,571
Change (1Y)
1,713
Growth (1Y)
11.53%
Revenue / Employee
4.03M INR
Profits / Employee
352.07K INR
Market Cap
202.74B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 347,362 |
| HDFC Bank | 214,521 |
| Tata Consultancy Services | 607,979 |
| Bharti Airtel | 28,673 |
| ICICI Bank | 187,765 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Hindustan Unilever | 18,802 |
Alembic Pharmaceuticals News
- 17 days ago - Alembic Pharma acquires UK-based Utility Therapeutics for $12 million to expand US presence - Business Upturn
- 20 days ago - Alembic Pharma share jump 3% after company gets US FDA approval for Doxorubicin Hydrochloride Injection - Business Upturn
- 4 weeks ago - Alembic Pharma receives EIR from USFDA for Karakhadi API-III facility - Business Upturn
- 4 weeks ago - Pharma stocks in focus as Trump announces tariffs on sector ‘soon’ - Business Upturn
- 6 weeks ago - Alembic Pharma shares dip over 2% after USFDA issues 4 observations for Panelav facility - Business Upturn
- 7 weeks ago - Alembic Pharmaceuticals shares in focus after USFDA nod for cancer drug Bosutinib - Business Upturn
- 2 months ago - Alembic Pharmaceuticals gets USFDA final approval for Amlodipine and Atorvastatin Tablets - Business Upturn
- 2 months ago - Alembic Pharma gets USFDA nod for Rivaroxaban tablets across four strengths; to launch 2.5 mg in Q1 FY26 - Business Upturn